Thinking of joining a study?

Register your interest

NCT06393530 | Not yet recruiting | Spine Fusion


Erector Spinae Plane Block for Cervical Spine Surgery
Sponsor:

Poznan University of Medical Sciences

Brief Summary:

The study aims to assess the interfacial plane blocks' effect on pain level, course of postoperative rehabilitation, and anti-inflammatory analgesic effect.

Condition or disease

Spine Fusion

Spine Disease

Spinal Disease

Intervention/treatment

0.9%sodium chloride

0.2% ropivacaine

Phase

Phase 4

Detailed Description:

This study evaluates the analgesic efficacy in adults of bilevel, bilateral erector spinae plane (ESP) blocks after posterior cervical spinal fusion surgery by assessing postoperative pain scores and opiate requirements as the primary outcome measures. We aim to investigate how ESP blocks, performed under ultrasound guidance at the two vertebral levels, contribute to postoperative pain control. This will be determined by measuring numerical rating pain scores repeatedly following surgery and opiate consumption until the patient is discharged from the hospital. These primary outcome measures will be compared between a treatment group of participants receiving ESP blocks and a control group receiving a sham block. Our primary hypothesis is that ESP blocks significantly reduce postoperative pain and opiate requirements.

Study Type : Interventional
Estimated Enrollment : 60 participants
Masking : Triple
Primary Purpose : Treatment
Official Title : Erector Spinae Plane Block for Cervical Spine Surgery. A Prospective, Randomized, Double-blinded Clinical Trial.
Actual Study Start Date : May 1, 2024
Estimated Primary Completion Date : May 30, 2025
Estimated Study Completion Date : June 30, 2025
Arm Intervention/treatment

Sham Comparator: Sham group

Bilateral ESPB under ultrasound guidance (adjusted to the incision line): 2 x 20ml/kg 0,9% normal saline

Drug: 0.9%sodium chloride

Active Comparator: ESPB group

Bilateral ESPB under ultrasound guidance (adjusted to the incision line): 2 x 20ml/kg 0.2% Ropivacaine

Drug: 0.2% ropivacaine

Ages Eligible for Study: 18 Years to 100 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • patients undergoing primary posterior cervical decompression and stabilization with instrumentation involving multi-levels in the cervical region,
  • aged >18 years and <100 years
  • ASA physical status 1, 2 or 3.
Exclusion Criteria
  • refuse to participate,
  • history of opioid abuse,
  • infection of the puncture site,
  • aged <18 years and >100 years
  • ASA 4 and 5

Erector Spinae Plane Block for Cervical Spine Surgery

Location Details


Please Choose a site



Erector Spinae Plane Block for Cervical Spine Surgery

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Poland, Poznań

Poznan University of Medical Sciences

Poznan, Poznań, Poland, 61-701

Loading...